High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study-Reference-Cited by-同舟云学术

High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study

Published:2004-11-05 Issue:5 Volume:127 Page:543-551
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Perz Jolanta B.,Schonland Stefan O.,Hundemer Michael,Kristen Arnt V.,Dengler Thomas J.,Zeier Martin,Linke Reinhold P.,Ho Anthony D.,Goldschmidt Hartmut

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2004.05232.x/fullpdf

Reference27 articles.

1. Effective treatment of advanced multiple myeloma refractory to alkylating agents;Barlogie;The New England Journal of Medicine,1984

2. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant;Blade;British Journal of Haematology,1998

3. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients;Comenzo;Blood,1998

4. Autologous stem cell transplantation for primary systemic amyloidosis;Comezo;Blood,2002

5. Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival;Dispenzieri;Journal of Clinical Oncology,2001

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PSORIASIS COMBINED WITH SYSTEMIC AMYLOIDOSIS: CLINICAL OBSERVATION;Acta medica Eurasica;2023-09-25

2. Vincristine, Doxorubicin, and Dexamethasone Induction before Autologous Stem Cell Transplantation in Patients with AL Amyloidosis: A Retrospective Comparison with Frontline Stem Cell Transplantation;Internal Medicine;2022-10-01

3. The role of induction therapy before autologous stem cell transplantation in low disease burden AL amyloidosis patients;Amyloid;2020-10-21

4. Regression of renal amyloid deposits by VAD therapy plus autologous stem cell transplantation in a patient with primary AL amyloidosis;CEN Case Reports;2019-09-14

5. Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell Transplantation;Biology of Blood and Marrow Transplantation;2018-11